Scientific article
English

Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells

Published in

MedChemComm, vol. 8, no. 1, p. 112-121

Publication date

2017

Abstract

Multiple myeloma (MM) remains an incurable malignancy despite the development of novel therapeutics. This is believed to be due to a subset of rare chemotherapy-resistant cancer stem cells (CSCs). Differentiation therapy represents one strategy aimed at reducing the stemness of CSCs. The anticancer effect of withaferin A (WFA) was studied in MM-CSCs and RPMI 8226 MM tumoral plasma cells (RPMIs). WFA exhibited growth inhibitory effects in both MM-CSCs and RPMIs, with IC50 values of 649 and 224 nM, respectively. WFA also induced a G2 cell cycle arrest, as well as cell death and apoptosis. Although, WFA did not exhibit a direct anti-migratory effect, a remarkable morphological change was observed in MM-CSCs in response to WFA treatment. Using qPCR gene expression analyses, WFA caused a reduction in stemness markers, and a promotion of differentiation markers in MM-CSCs. These results warrant further investigation of WFA in relevant MM animal models.

UNIGE research groups

Citation (ISO format)

ISSA, Mark Elia, CUENDET, Muriel. Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells. In: MedChemComm, 2017, vol. 8, n° 1, p. 112–121. doi: 10.1039/C6MD00410E

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

http://xlink.rsc.org/?DOI=C6MD00410E

Journal ISSN

2040-2503
454views
0downloads

Technical informations

Creation

14/06/2017 10:06:00

First validation

14/06/2017 10:06:00

Update

15/03/2023 01:47:22

Status update

15/03/2023 01:47:21

Last indexation

31/10/2024 07:12:16
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated